Kanya Rajangam insider trades

Open-market stock purchases and sales by Kanya Rajangam, Pres. & Chief Med. & Dev. Off. at Senti Biosciences, Inc, from SEC Form 4 filings since Jul 9, 2020.

Recent trades

DateStockTradeValue
Mar 9, 2026SNTI Senti Biosciences, IncSold (not open market)—
Feb 2, 2026SNTI Senti Biosciences, IncSold (not open market)—

Companies traded

  • SNTI Senti Biosciences, Inc: 2 sales, last Mar 9, 2026
  • TSBX Turnstone Biologics Corp: other filings, last Jun 3, 2024
  • NKTX Nkarta, Inc: 1 sale, last Jan 14, 2022

Get free alerts when Kanya Rajangam files a new trade →